Covid-19 has disrupted the world economy and healthcare system. Even after recovering from Kovid-19 infection, people are still experiencing breathing and other symptom problems. According to the report, Kovid-19 patients have experienced headaches, confusion and other neurological symptoms. However, doctors have not yet understood how diseases target the brain once a person is infected with Covid-19.Also read – Home from work ends for Cognizant employees: How is the IT major planning to return to office from April 18? Read here
And now, researchers have discovered severe brain inflammation and injury consistent with a decrease in blood flow or oxygen to the brain, including damage and death to neurons. Also read – 4th Covid Wave Coming Soon? China has the highest daily COVID surge in 2 years; The UK sees around 5 million cases
The findings, published in the journal Nature Communications, are said to be the first comprehensive assessment of neuropathology associated with SARS-CoV-2 infection in a non-human primate model. Also read – Haryana relaxes Kovid guidelines, withdraws fines for not wearing masks in public places
The study also found minor bleeding in the brain. Surprisingly, these findings were present in subjects who had not experienced severe respiratory disease from the virus.
“Because the subjects did not show significant respiratory symptoms, no one expected them to have the severity of the brain disease,” said Tracy Fisher, chief investigator at Tullen University in the U.S.
“But the findings were different and profound, and undeniably the result of an infection,” Fisher added.
The researchers said the findings were also consistent with an autopsy study of people who had died from Covid-19, suggesting that inhumane primates could serve as a suitable model or proxy for how humans experience disease.
Neurological complications are often among the first symptoms of SARS-CoV-2 infection and can be the most serious and persistent. They also affect people of all ages – with and without concomitant diseases, and with varying degrees of disease severity.
(With IANS inputs)
